Pages that link to "Q37670668"
Jump to navigation
Jump to search
The following pages link to E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia. (Q37670668):
Displaying 10 items.
- Pharmacological therapeutics in Friedreich ataxia: the present state (Q39445743) (← links)
- Overexpression of Drosophila frataxin triggers cell death in an iron-dependent manner. (Q47793738) (← links)
- RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHK1 inhibitor efficacy in breast cancer cells (Q50077606) (← links)
- Biophysical characterisation of the recombinant human frataxin precursor. (Q52365070) (← links)
- Emerging therapeutics for the treatment of Friedreich’s ataxia (Q56700247) (← links)
- Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia (Q58697859) (← links)
- RNF126 Quenches RNF168 Function in the DNA Damage Response (Q64388640) (← links)
- Non-Thermal Plasma Induces Antileukemic Effect Through mTOR Ubiquitination (Q90047795) (← links)
- High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer (Q91618333) (← links)
- Frataxin Structure and Function (Q92651143) (← links)